Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants

European Journal of Clinical Pharmacology

Volumn 51, Issue 1, 1996, Pages 69-72

  Vauzelle Kervroedan, F ^a   Rey, E ^a   Pariente Khayat, A ^a   Bienvenu, T ^a   Badoual, J ^a   Olive, G ^a   Pons, G ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

6 OHF FF ratio; CYP IIIA3 4; CYP IIIA7; Cytochrome 450 IIIA; Drug metabolism; Infants; Maturation; Neonates

Indexed keywords

CYTOCHROME P450 ISOENZYME;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INFANT; MATURATION; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

AGE FACTORS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIVER; MALE; OXIDOREDUCTASES, N-DEMETHYLATING; REGRESSION ANALYSIS;

EID: 0029777548     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050162     Document Type: Article

References (13)

1. Pariente-Khayat A, Pons G, Rey E, Richard MO, d' Athis P, Moran C, Badoual J, Olive G (1991) Caffeine acetylator phenotyping during maturation in infants. Pediatr Res 29:492-495
2. Saenger P, Forster E, Kream J (1981) 6 β-hydroxycortisol: a noninvasive indicator of enzyme induction. J Clin Endocrinol Metab 52:381-384
3. Moreland TA, Park BK, Rylance GW (1982) Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 β-hydroxycortisol excretion and plasma γ-glutamyltranspeptidase activity. Br J Clin Pharmacol 14:861-865
4. Desager JP, Dumont E, Harvengt C (1987) The urinary 6 β-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase. Pharmacol Ther 33:197-199
5. Ohnhaus EE, Breckenridge AM, Park BK (1989) Urinary excretion of 6 β-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 36:39-46
6. Saenger P (1983) 6 β-hydroxycortisol in random urine samples as an indicator of enzyme induction. Clin Pharmacol Ther 34:818-823
7. Bienvenu T, Rey E, Pons G, d'Athis P, Olive G (1991) A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans. Int J Clin Pharmacol Ther Toxicol 29:441-445
8. Chul L (1995) Urinary 6 β-hydroxycortisol in humans: analysis, biological variations, and reference ranges. Clin Biochem 28:49-54
9. Ged C, Rouillon JM, Pichard L, Combalbert J, Bressot N, Bories P, Michel H, Beaune P, Maurel P (1989) The increase in urinary excretion of 6 β-hydroxycortisol as a marker of human hepatic CYP IIIA induction. Br J Clin Pharmacol 28:373-387
10. Juchau MR, Chao ST, Omiecinski CJ (1980) Drug metabolism by the human fetus. Clin Pharmacokinet 5:320-339
11. Raucy JL, Carpenter SJ (1993) The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J Pharmacol Toxicol Methods 29:121-128
12. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Mäenpää J, Rane A, Raunio H (1994) Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 48:59-64
13. Treluyer JM, Jacqz-Aigrain K, Alvarez F, Cresteil T (1991) Expression of CYP 2D6 in developing human liver. Eur J Biochem 202:583-588